- Home
- CNSP vs IBG Comparison
CNSP vs IBG Comparison
Compare CNSP & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNSP
- IBG
- Stock Information
- Founded
- CNSP 2017
- IBG 2018
- Country
- CNSP United States
- IBG Australia
- Employees
- CNSP N/A
- IBG N/A
- Industry
- CNSP Biotechnology: Pharmaceutical Preparations
- IBG Beverages (Production/Distribution)
- Sector
- CNSP Health Care
- IBG Consumer Staples
- Exchange
- CNSP Nasdaq
- IBG Nasdaq
- Market Cap
- CNSP 5.4M
- IBG 6.1M
- IPO Year
- CNSP 2019
- IBG 2024
- Fundamental
- Price
- CNSP $0.11
- IBG $1.05
- Analyst Decision
- CNSP Strong Buy
- IBG
- Analyst Count
- CNSP 1
- IBG 0
- Target Price
- CNSP $0.50
- IBG N/A
- AVG Volume (30 Days)
- CNSP 41.4M
- IBG 888.3K
- Earning Date
- CNSP 11-15-2024
- IBG 01-01-0001
- Dividend Yield
- CNSP N/A
- IBG N/A
- EPS Growth
- CNSP N/A
- IBG N/A
- EPS
- CNSP N/A
- IBG N/A
- Revenue
- CNSP N/A
- IBG $3,147,763.00
- Revenue This Year
- CNSP N/A
- IBG N/A
- Revenue Next Year
- CNSP N/A
- IBG N/A
- P/E Ratio
- CNSP N/A
- IBG N/A
- Revenue Growth
- CNSP N/A
- IBG N/A
- 52 Week Low
- CNSP $0.10
- IBG $0.60
- 52 Week High
- CNSP $137.50
- IBG $3.35
- Technical
- Relative Strength Index (RSI)
- CNSP 37.06
- IBG N/A
- Support Level
- CNSP $0.10
- IBG N/A
- Resistance Level
- CNSP $0.13
- IBG N/A
- Average True Range (ATR)
- CNSP 0.02
- IBG 0.00
- MACD
- CNSP 0.00
- IBG 0.00
- Stochastic Oscillator
- CNSP 8.50
- IBG 0.00
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter and retailer of a growing beverage portfolio of 60 formulations across 13 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands.